ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01283035
Brief Title: A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

First Submitted : January 24, 2011
First Submitted that Met QC Criteria : January 24, 2011
First Posted : January 25, 2011 (Estimate)

Results First Submitted : February 16, 2016
Results First Submitted that Met QC Criteria : May 16, 2016
Results First Posted : June 24, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 16, 2016
Last Update Posted : June 24, 2016 (Estimate)